Roivant Historical Income Statement

ROIV Stock

USD 11.82 0.33 2.87%

Historical analysis of Roivant Sciences income statement accounts such as Total Revenue of 131 M, Gross Profit of 114.7 M, Other Operating Expenses of 4.3 B or Operating Income of 4.5 B can show how well Roivant Sciences performed in making a profits. Evaluating Roivant Sciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Roivant Sciences's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Roivant Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Roivant Sciences is a good buy for the upcoming year.

Net Income Gross Profit

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Roivant Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Roivant Stock please use our How to Invest in Roivant Sciences guide.

About Roivant Income Statement Analysis

Roivant Sciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Roivant Sciences shareholders. The income statement also shows Roivant investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Roivant Sciences Income Statement Chart

At this time, Roivant Sciences' Net Income is fairly stable compared to the past year. Income Tax Expense is likely to climb to about 23.3 M in 2024, whereas Depreciation And Amortization is likely to drop slightly above 20.9 M in 2024.

Selling General Administrative Total Revenue Gross Profit Ebit

Total Revenue

Total revenue comprises all receipts Roivant Sciences generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Roivant Sciences minus its cost of goods sold. It is profit before Roivant Sciences operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Most accounts from Roivant Sciences' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Roivant Sciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Roivant Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Roivant Stock please use our How to Invest in Roivant Sciences guide.At this time, Roivant Sciences' Net Income is fairly stable compared to the past year. Income Tax Expense is likely to climb to about 23.3 M in 2024, whereas Depreciation And Amortization is likely to drop slightly above 20.9 M in 2024.

	2021	2022	2023	2024 (projected)
Interest Expense	7.0M	28.0M	34.8M	36.5M
Depreciation And Amortization	5.9M	18.9M	22.0M	20.9M

Interest Expense Depreciation And Amortization

Roivant Sciences income statement Correlations

	Discontinued Operations	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Minority Interest	Tax Provision	Net Interest Income	Interest Income	Net Income From Continuing Ops	Reconciled Depreciation	Non Operating Income Net Other
Discontinued Operations		-0.46	0.19	0.38	0.57	0.61	0.18	0.16	0.16	-0.73	0.08	0.28	-0.15	0.18	0.25	0.43	0.3	-0.5	0.17	0.16	0.18	0.16	0.21	0.21
Depreciation And Amortization	-0.46		-0.68	-0.89	-0.84	-0.81	-0.7	-0.49	-0.49	0.28	-0.33	-0.89	0.48	-0.54	-0.62	-0.59	-0.56	0.75	-0.61	-0.58	-0.64	-0.55	-0.73	-0.74
Interest Expense	0.19	-0.68		0.66	0.86	0.84	0.89	0.84	0.83	0.19	0.76	0.92	-0.83	0.84	-0.07	0.82	0.9	-0.52	0.92	0.88	0.93	0.84	0.97	0.99
Selling General Administrative	0.38	-0.89	0.66		0.79	0.77	0.65	0.46	0.47	0.04	0.33	0.88	-0.45	0.5	0.62	0.54	0.51	-0.86	0.55	0.53	0.59	0.51	0.7	0.68
Total Revenue	0.57	-0.84	0.86	0.79		1.0	0.89	0.82	0.82	-0.22	0.72	0.91	-0.81	0.84	0.28	0.91	0.89	-0.63	0.87	0.85	0.88	0.84	0.83	0.84
Gross Profit	0.61	-0.81	0.84	0.77	1.0		0.88	0.82	0.82	-0.26	0.72	0.88	-0.81	0.84	0.27	0.92	0.89	-0.6	0.86	0.85	0.87	0.84	0.8	0.82
Other Operating Expenses	0.18	-0.7	0.89	0.65	0.89	0.88		0.96	0.96	0.03	0.9	0.87	-0.95	0.97	0.17	0.93	0.95	-0.34	0.98	0.98	0.98	0.98	0.82	0.84
Operating Income	0.16	-0.49	0.84	0.46	0.82	0.82	0.96		1.0	0.04	0.98	0.73	-1.0	1.0	-0.06	0.96	0.98	-0.15	0.98	0.99	0.97	1.0	0.75	0.77
Ebit	0.16	-0.49	0.83	0.47	0.82	0.82	0.96	1.0		0.06	0.98	0.73	-1.0	1.0	-0.03	0.96	0.98	-0.16	0.98	0.99	0.97	1.0	0.74	0.76
Research Development	-0.73	0.28	0.19	0.04	-0.22	-0.26	0.03	0.04	0.06		0.12	0.07	-0.05	0.02	-0.32	-0.17	-0.03	-0.01	0.06	0.04	0.06	0.03	0.14	0.13
Ebitda	0.08	-0.33	0.76	0.33	0.72	0.72	0.9	0.98	0.98	0.12		0.61	-0.98	0.97	-0.15	0.92	0.94	-0.02	0.94	0.96	0.92	0.97	0.65	0.67
Cost Of Revenue	0.28	-0.89	0.92	0.88	0.91	0.88	0.87	0.73	0.73	0.07	0.61		-0.72	0.76	0.31	0.75	0.79	-0.72	0.83	0.8	0.86	0.77	0.92	0.93
Total Operating Expenses	-0.15	0.48	-0.83	-0.45	-0.81	-0.81	-0.95	-1.0	-1.0	-0.05	-0.98	-0.72		-1.0	0.07	-0.96	-0.98	0.13	-0.98	-0.99	-0.97	-0.99	-0.75	-0.76
Income Before Tax	0.18	-0.54	0.84	0.5	0.84	0.84	0.97	1.0	1.0	0.02	0.97	0.76	-1.0		0.02	0.97	0.98	-0.18	0.98	0.99	0.98	1.0	0.75	0.77
Total Other Income Expense Net	0.25	-0.62	-0.07	0.62	0.28	0.27	0.17	-0.06	-0.03	-0.32	-0.15	0.31	0.07	0.02		0.05	-0.07	-0.47	-0.02	0.0	0.01	0.03	-0.04	-0.04
Net Income	0.43	-0.59	0.82	0.54	0.91	0.92	0.93	0.96	0.96	-0.17	0.92	0.75	-0.96	0.97	0.05		0.98	-0.29	0.94	0.95	0.94	0.96	0.74	0.76
Income Tax Expense	0.3	-0.56	0.9	0.51	0.89	0.89	0.95	0.98	0.98	-0.03	0.94	0.79	-0.98	0.98	-0.07	0.98		-0.27	0.98	0.98	0.98	0.97	0.82	0.84
Minority Interest	-0.5	0.75	-0.52	-0.86	-0.63	-0.6	-0.34	-0.15	-0.16	-0.01	-0.02	-0.72	0.13	-0.18	-0.47	-0.29	-0.27		-0.27	-0.23	-0.32	-0.19	-0.54	-0.56
Tax Provision	0.17	-0.61	0.92	0.55	0.87	0.86	0.98	0.98	0.98	0.06	0.94	0.83	-0.98	0.98	-0.02	0.94	0.98	-0.27		1.0	1.0	0.98	0.85	0.87
Net Interest Income	0.16	-0.58	0.88	0.53	0.85	0.85	0.98	0.99	0.99	0.04	0.96	0.8	-0.99	0.99	0.0	0.95	0.98	-0.23	1.0		0.99	1.0	0.81	0.83
Interest Income	0.18	-0.64	0.93	0.59	0.88	0.87	0.98	0.97	0.97	0.06	0.92	0.86	-0.97	0.98	0.01	0.94	0.98	-0.32	1.0	0.99		0.98	0.87	0.89
Net Income From Continuing Ops	0.16	-0.55	0.84	0.51	0.84	0.84	0.98	1.0	1.0	0.03	0.97	0.77	-0.99	1.0	0.03	0.96	0.97	-0.19	0.98	1.0	0.98		0.76	0.78
Reconciled Depreciation	0.21	-0.73	0.97	0.7	0.83	0.8	0.82	0.75	0.74	0.14	0.65	0.92	-0.75	0.75	-0.04	0.74	0.82	-0.54	0.85	0.81	0.87	0.76		0.98
Non Operating Income Net Other	0.21	-0.74	0.99	0.68	0.84	0.82	0.84	0.77	0.76	0.13	0.67	0.93	-0.76	0.77	-0.04	0.76	0.84	-0.56	0.87	0.83	0.89	0.78	0.98

Click cells to compare fundamentals

Roivant Sciences Account Relationship Matchups

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Roivant Stock Analysis

When running Roivant Sciences' price analysis, check to measure Roivant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roivant Sciences is operating at the current time. Most of Roivant Sciences' value examination focuses on studying past and present price action to predict the probability of Roivant Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roivant Sciences' price. Additionally, you may evaluate how the addition of Roivant Sciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Roivant Historical Income Statement

About Roivant Income Statement Analysis

Roivant Sciences Income Statement Chart

Total Revenue

Gross Profit

Roivant Sciences income statement Correlations

Roivant Sciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Roivant Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Gross Profit	+ 1.0	Total Revenue
Ebit	+ 1.0	Operating Income
Income Before Tax	+ 1.0	Operating Income
Net Income From Continuing Ops	+ 1.0	Operating Income
Income Before Tax	+ 1.0	Ebit
Net Income From Continuing Ops	+ 1.0	Ebit

Income Before Tax	- 1.0	Total Operating Expenses
Total Operating Expenses	- 1.0	Ebit
Total Operating Expenses	- 1.0	Operating Income
Net Income From Continuing Ops	- 0.99	Total Operating Expenses
Net Interest Income	- 0.99	Total Operating Expenses
Tax Provision	- 0.98	Total Operating Expenses